MATTHEW SCHULTZ: Open Payments
NPI 1124096797 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$955 in 65 payments from 4 companies in 2025. Trend: 2023 $482 · 2024 $824 · 2025 $955
Food & beverage: $955
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 33 | $443 |
| ABBVIE INC. | 27 | $396 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
Products named: TREMFYA, RINVOQ, CREON, ENTYVIO, DUPIXENT, LINZESS, EOHILIA, SKYRIZI.
Industry payments across PA — which companies pay providers there.
